Published in Vopr Onkol on January 01, 1980
Downregulation of VEGF-C expression in lung and colon cancer cells decelerates tumor growth and inhibits metastasis via multiple mechanisms. Oncogene (2011) 1.26
Chromosome changes caused by alterations of p53 expression. Mutat Res (1996) 1.22
11q deletions in human colorectal carcinomas: cytogenetics and restriction fragment length polymorphism analysis. Genes Chromosomes Cancer (1993) 1.05
Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells. Biochemistry (Mosc) (2008) 1.04
Disruption of actin microfilaments by cytochalasin D leads to activation of p53. FEBS Lett (1998) 1.00
Activation of p53-mediated cell cycle checkpoint in response to micronuclei formation. J Cell Sci (1998) 0.94
P53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints. Oncogene (1999) 0.94
p53 does not control the spindle assembly cell cycle checkpoint but mediates G1 arrest in response to disruption of microtubule system. Cell Biol Int (1999) 0.93
p53 activation in response to microtubule disruption is mediated by integrin-Erk signaling. Oncogene (2001) 0.93
p53 hot-spot mutants increase tumor vascularization via ROS-mediated activation of the HIF1/VEGF-A pathway. Cancer Lett (2008) 0.91
[Relation between the attachment of cells to a substrate and their proliferative characteristics]. Eksp Onkol (1984) 0.89
[Effect of on various cell lines of p53 cDNA, expressed under the control of an exogenous homologous promotor]. Mol Biol (Mosk) (1995) 0.86
Restoration of p53 tumor-suppressor activity in human tumor cells in vitro and in their xenografts in vivo by recombinant avian adenovirus CELO-p53. Gene Ther (2004) 0.86
Specific karyotypic alterations in colchicine-resistant cells. Cytogenet Cell Genet (1981) 0.86
Cell-specific effects of RAS oncogene and protein kinase C agonist TPA on P-glycoprotein function. FEBS Lett (1995) 0.86
Karyotype peculiarities of human colorectal adenocarcinomas. Hum Genet (1991) 0.85
[Functional heterogeneity of p53-responsive elements]. Mol Biol (Mosk) (1996) 0.85
Gene amplification in Djungarian hamster cell lines possessing decreased plasma membrane permeability for colchicine and some other drugs. Chromosoma (1985) 0.82
Comparison of mitostatic effect, cell uptake and tubulin-binding activity on colchicine and colcemid. Biochim Biophys Acta (1981) 0.81
Cloning and characterization of DNA sequences amplified in multidrug-resistant Djungarian hamster and mouse cells. Somat Cell Mol Genet (1987) 0.81
[Role of PTEN protein in multidrug resistance of prostate cancer cells]. Mol Biol (Mosk) (2008) 0.80
Colcemid-induced polyploidy and aneuploidy in normal and tumour cells in vitro. Int J Cancer (1975) 0.80
Distinct effects of various p53 mutants on differentiation and viability of human K562 leukemia cells. Oncol Res (1997) 0.79
Regular pattern of karyotypic alterations accompanying gene amplification in Djungarian hamster cells: study of colchicine, adriablastin, and methotrexate resistance. Chromosoma (1985) 0.79
[The protective role of p53 in Ras-induced transformation of REF52 cells]. Mol Biol (Mosk) (2003) 0.79
[Gene expression of vascular endothelial growth factors and their receptors in different variants of the course of multiple myeloma]. Ter Arkh (2013) 0.78
[Effect of inactivating the p33ING1 tumor suppressor on the function of cell cycle "checkpoints" and genome stability]. Genetika (2000) 0.78
[Determination of the amount of YB-1 gene mRNA in the breast tumor tissues to predict the course of disease]. Klin Lab Diagn (2010) 0.77
[The human adenosine deaminase gene contains a p53-responsive element]. Dokl Akad Nauk (1996) 0.77
[Hyperproduction of a specific protein in cells resistant to colchicine and adriablastin]. Biull Eksp Biol Med (1983) 0.77
[Connection of intracellular protein YB-1 localization in cell cultures of human tumors with multidrug resistance]. Vopr Onkol (2013) 0.76
[Construction of chimeric tumor suppressor p53 resistant to the dominant-negative interaction with p53 mutants]. Mol Biol (Mosk) (2002) 0.76
Decreased sensitivity of multidrug-resistant tumor cells to cisplatin is correlated with sorcin gene co-amplification. Neoplasma (1995) 0.76
[Mutation of p53 is necessary for stable transformation of REF52 cells by myc+ras oncogenes]. Mol Biol (Mosk) (2000) 0.76
[Specific karyotype changes in cells resistant to colchicine]. Genetika (1981) 0.75
[Effects of various mutant p53 on the sensitivity of cells to cytostatics]. Biull Eksp Biol Med (1999) 0.75
[Relation of mammalian cell resistance to actinomycin D with a change in the karyotype and a decrease in cytoplasmic membrane permeability]. Genetika (1981) 0.75
[The effect of the tumor suppressor p53 and its mutant forms on the differentiation and viability of K562 leukemic cells]. Tsitologiia (1996) 0.75
[Genetic study of the resistance of mouse somatic cells to colchicine (high resistance level)]. Genetika (1979) 0.75
[Relationship between amplicon composition and cytologic type of structures containing amplified DNA in murine P388 cells with multiple drug resistance]. Genetika (1995) 0.75
[The cells of murine sarcoma PC-103 induced by a polymeric plate secret transforming growth factor alpha]. Eksp Onkol (1990) 0.75
[Effect of some drugs on colchicine uptake by colchicine-sensitive and resistant cells]. Biull Eksp Biol Med (1979) 0.75
[Comparative sensitivity of normal and neoplastic cells to the mitostatic action of colcemid]. Tsitologiia (1973) 0.75
[Karyotypic characteristics and the transplantability of certain mammalian cell lines]. Vopr Onkol (1974) 0.75
[Pattern of evolution of amplicons during the development of multiple drug resistance in Djungarian hamster cells]. Mol Gen Mikrobiol Virusol (1987) 0.75
[Increased tendency to chromosome nondisjunction arising as a result of Robertsonian translocations]. Genetika (1974) 0.75
[Characteristics of the karyotype changes in Djungarian hamster cells resistant to methotrexate]. Genetika (1983) 0.75
[Stimulation of differentiation of LIM 1215 large intestinal tumor cells during expression of the p53 exogenous antioncogene or the activated ras oncogene]. Arkh Patol (1996) 0.75
[Genome instability and oncogenesis]. Mol Biol (Mosk) (2007) 0.75
[Chromosomal and extrachromosomal localization of amplified genes in colchicine-resistant cells]. Dokl Akad Nauk SSSR (1982) 0.75
[Role of the nucleus and the cytoplasm in determining the change in the permeability for colchichine of the plasma membrane of mouse cells]. Genetika (1982) 0.75
[Genetic study of stable inheritable cell resistance to colchicine. Chromosomal and hybridization analysis]. Genetika (1982) 0.75
[Amplification of genome regions in the somatic cells of mammals resistant to colchicine. III. Localization of the amplified genes in minute chromatin bodies]. Genetika (1982) 0.75
[Opposite effect of p53 on nucleotide metabolizing enzyme activity in Rat1 cells and their sublines, transformed by N-RAS or v-mos oncogenes]. Biokhimiia (1995) 0.75
[Gene amplification in murine leukemia cells with multiple drug resistance acquired in vivo]. Genetika (1987) 0.75
[Amplification of portions of the genome in mammalian somatic cells resistant to colchicine. VI. Restriction analysis of the amplified DNA sequences]. Genetika (1983) 0.75
[Mouse cell line with stable inheritance of colchicine resistance]. Biull Eksp Biol Med (1981) 0.75
[Priorities in research of hemoblastosis]. Vestn Ross Akad Med Nauk (1999) 0.75
[Genetic analysis of a characteristic of transformed cells--proliferation not dependent on the substrate]. Vestn Akad Med Nauk SSSR (1984) 0.75
[Induction of gene amplification in Djungarian hamster cells by various chemical carcinogens]. Biull Eksp Biol Med (1986) 0.75
[L-cell substrain resistant to metaphase inhibitors]. Biull Eksp Biol Med (1973) 0.75
[Segments of Djungarian hamster chromosomes, specific for translocation of integration of amplified mdr1 genes, do not possess increased instability]. Genetika (1991) 0.75
[Dominant-negative inactivation of p53: the effect of the proportion between trans-dominant inhibitor and its target]. Mol Biol (Mosk) (2003) 0.75
[Functional activity and expression of P-glycoprotein in chronic myeloid leukemia]. Ter Arkh (2001) 0.75
Enhanced expression of 1p32 and 1p22 fragile sites in lymphocytes in cutaneous malignant melanomas. Cancer Genet Cytogenet (1992) 0.75
[Increasing the sensitivity of cells, resistant to colchicine, by means of the nonionic detergent Tween-80]. Dokl Akad Nauk SSSR (1974) 0.75
[Genetic analysis of the resistance of mouse somatic cells to colchicine]. Genetika (1978) 0.75
[In vitro induction of numerical changes in the karyotype of normal and transformed Djungarian and Chinese hamster cells]. Genetika (1975) 0.75
[Progress in understanding moleculr mechanisms of oncogenesis, and novel methods of tumor growth control]. Vestn Ross Akad Med Nauk (2007) 0.75
[Specific DNA-binding properties of oncoprotein p53 in human tumor cells]. Dokl Akad Nauk (1993) 0.75
[The differentiation of tumor cells of the human large intestine during the acquisition of multiple drug resistance]. Arkh Patol (1994) 0.75
[Studies of YB-1 protein in breast tumors]. Klin Lab Diagn (2009) 0.75
[p53 with a mutation in codon 273 increases the probability of amplifying the dhfr gene in Rat-1 and LIM1215 cells]. Genetika (1995) 0.75
[Changes in the genotype and phenotype determining the resistance of Djungarian hamster somatic cells to adriablastin]. Biull Eksp Biol Med (1983) 0.75
[Transplantable leukemia in mice with multiple central chromosome fusions]. Vopr Onkol (1971) 0.75
[Mechanism of colchicine resistance of mouse L cell sublines]. Dokl Akad Nauk SSSR (1973) 0.75
[New Djungarian hamster cell lines with selective cytoplasmic and nuclear genetic markers]. Genetika (1982) 0.75
[Isolation of DNA probes for the detection of sequences amplified in colchicine-resistant cells]. Mol Biol (Mosk) (1986) 0.75
[Cloning and characteristics of DNA sequences amplified in Djungarian hamster cells with multidrug resistance]. Mol Gen Mikrobiol Virusol (1987) 0.75
Newly formed chromosome-like structures in independent mouse P388 sublines with developed in vivo mdr1 gene amplification. Somat Cell Mol Genet (1991) 0.75
[Clonal structure of tumors: difference between clones based on the ability to secrete growth-regulating factors and to react to them]. Biull Eksp Biol Med (1986) 0.75
[Effect of inactivating various components of the signal pathways of the tumor suppressor p53 on genomic stability]. Genetika (1999) 0.75
[Effect of colcemid on cell movement, mitosis and DNA synthesis in a culture of mouse embryonic fibroblast-like cells]. Biull Eksp Biol Med (1972) 0.75
[Oncogenes, antioncogenes and carcinogenesis]. Arkh Patol (1990) 0.75
[Identification of genes activated by mutant forms of p53]. Mol Biol (Mosk) (2000) 0.75
[Multiple drug resistance and differentiation in the population of transformed dog kidney cells MDCK]. Mol Gen Mikrobiol Virusol (1990) 0.75
[On congenital anomalies in the karyotype of patients with acute leukosis]. Vopr Onkol (1968) 0.75
[In vitro induction of numerical changes in the karyotype of normal and transformed cells of Dzhungarian and Chinese hamsters]. Genetika (1975) 0.75